Clinical Trial Update: QUILT-3.091 NANT Chordoma Vaccine vs Radiation in Subjects With Unresectable Chordoma. [Phase 1, Phase 2]

View source ↗

Summary

The Phase 1/2 trial QUILT-3.091 evaluating the NANT Chordoma Vaccine versus radiation for unresectable chordoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chordoma

Drugs mentioned

• NANT Chordoma Vaccine

Snippet

Sponsor: ImmunityBio, Inc. | Conditions: Chordoma, Unresectable Malignant Neoplasm | Phase 1, Phase 2 | Status: WITHDRAWN